Concurrent vinablastine-based radiochemotherapy was evaluated in 84 bladder-cancer patients. It was effective in more than half: tumour-specific survival (51% 9-year), local control rate (55% 9-year). The drawback was the impaired function of the bladder (9-year prevalence SOMA G3-4 symptoms: 66%), indicating the need for treatment aimed at reducing chronic morbidity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.radonc.2005.01.007 | DOI Listing |
Publication Analysis
Top Keywords
phase study
4
study radiochemotherapy
4
radiochemotherapy vinblastine
4
vinblastine invasive
4
invasive bladder
4
bladder cancer
4
cancer concurrent
4
concurrent vinablastine-based
4
vinablastine-based radiochemotherapy
4
radiochemotherapy evaluated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!